MARATTO

article · Pan African Medical Journal

Diagnostic and therapeutic challenges of a heparin-induced thrombocytopenia in HIV immunodeficiency: in regards to a pediatric case (a case report)

20251 citationOpen accessAbdelmalek Essaâdi University

Abstract

We are dealing with a female infant case who had a cerebral venous thrombosis, revealing a secondary immunodeficiency, owing to a human immunodeficiency virus infection. After anticoagulant treatment with low-molecular-weight heparin (LMWH), it came to light that she had a severe thrombocytopenia, suggesting a thrombocytopenia induced by an auto-immune origin of heparin. Within a developing country in which means of confirmation are not always available, it was difficult to identify whether severe thrombocytopenia was owing to HIV infection, sepsis, or heparin. The therapeutic decision was therefore difficult, because stopping anticoagulation can lead to a cerebral thrombosis extension.

Research topics

  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Venous Thromboembolism Diagnosis and Management
  • Intramuscular injections and effects

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.11604/pamj.2025.51.43.46466

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.